DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for Tendinopathy — screening already-approved drugs against its 22-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleTendinopathy maps to a 22-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for tendinopathy is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
interleukin 17A (IL17A) — IL17A is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet 9's,17'rdrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 5HI4 · 1.8 Å · ligand (9'S,17'R)-6'-chloro-N-methyl-9'-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-10',19'-dioxo-2'-oxa-11',18'-diazaspiro[cyclopentane-1,21'-tetracyclo[20.2.2.2~12,15~.1~3,7~]nonacosane]-1'(24'),3'(29'),4',6',12',14',22',25',27'-nonaene-17'-carboxamide (63P). Experimental structure, not a prediction.
What the evidence adds up to
Tendinopathy is now understood as a degenerative process rather than a primarily inflammatory one, based on histologic evidence showing an absence of inflammatory cells. The condition is long-lasting, debilitating, and imposes a significant socioeconomic burden. Despite advances in technology, the ultimate cure for tendon pathology continues to elude current science, and the number of different theories and treatment modalities in the literature may confuse clinicians and patients. Available treatments — including medications, rehabilitation, modalities, injections, and minimally invasive procedures — have limited evidence of any significant long-term effect on the disease course.
A 2023 retrospective observational study of amateur runners with subacute Achilles tendinopathy compared ultrasound therapy alone (15 patients) with ultrasound therapy combined with cryotherapy (15 patients). Both groups underwent 10 sessions of ultrasound therapy plus stretching and eccentric exercises. All evaluations showed significant improvement over time in both groups. The cryo-ultrasound group showed a greater increase in pain and function at the first follow-up compared to the ultrasound-only group. By the final follow-up, both groups had improved, and a statistically significant difference was found between baseline and final values. The authors call for future studies with larger patient samples and longer follow-up to better evaluate the benefits.
A 2022 clinical perspective argues that manual therapy has not been well described in the management of tendinopathy, even though its indications — mobility deficits, muscle performance impairments, pain, and possible altered central pain processing — match the impairments associated with the condition. The authors note that despite strong evidence supporting exercise and load-management, a substantial proportion of individuals do not achieve a satisfactory long-term outcome.
Emerging hypotheses suggest that tendinopathy in different tendons, and even different regions within a tendon, may be distinct diseases. Phenotypic differences exist in the compositional, material, and cellular properties of load-bearing versus positional tendons, evident during early growth and well established by adulthood. Key drivers believed critical in onset and progression include mechanical stress, inflammation, and vascular changes, which interact to form a complex signaling network referred to as the tendinopathic loop. This network is expected to become more intricate with emerging concepts such as intratendinous pressure and metabolic factors. What remains missing is a clear understanding of the underlying pathomechanisms, which limits treatment options. Better patient stratification by tendon type and disease phenotype, along with adequately powered randomised trials with long follow-up, are needed before any intervention can be said to alter the disease course.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
The Physician and Sportsmedicine · 2013 · 21 citations
Tendinopathy: A Review of the Pathophysiology and Evidence for Treatment
AbstractThe understanding of tendinopathy has evolved over the past several decades. Initially thought to be a primarily inflammatory process, histologic evaluation has revealed that there is an absence of inflammatory cells, and rather, tendinopathy is more of a degenerative process. Various types of medications, rehabilitation, modalities, injections, and minimally invasive procedures have been described as treatment for this condition. The purpose of our article is to describe the pathophysiology of tendinopathy as currently understood and the evidence for the various available treatments. We performed a literature search to determine the types of reviews that have been performed previously regarding treatment for tendinopathy, and summarized these reviews. We then performed a systematic review of randomized controlled trials for treating patients with tendinopathy. It is our hope that our review of trial data will help providers to determine optimal management for their patients with tendinopathy.
Advanced Science · 2025 · 15 citations · open access
Tendinopathy: The Interplay between Mechanical Stress, Inflammation, and Vascularity
AbstractTendinopathy is a long-lasting, debilitating disease that not only affects patients' individual lives, but also imposes a significant socioeconomic burden. Due to an insufficient understanding of the underlying pathomechanisms, treatment options remain limited. Although tendinopathy is recognized as a multifactorial disorder, known risk factors and predisposing conditions have largely been studied in isolation. In this review, it is aimed to examine the various pathomechanisms identified to date and synthesize them into a unified concept. Particular emphasis is placed on key drivers believed to be critical in the onset and progression of the disease-namely mechanical stress, inflammation, and vascular changes. By exploring molecular signaling pathways and conditions involved in tendinopathy, how these mechanisms interact and reinforce one another is illustrated, forming a complex and dynamic signaling network, referred to as the tendinopathic loop. In the future, this network is expected to become even more intricate with the inclusion of emerging concepts such as intratendinous pressure and the potential influence of metabolic factors.
Postgraduate Medical Journal · 2019 · 15 citations
Revolving doors of tendinopathy: definition, pathogenesis and treatment
AbstractThe ultimate cure for the tendon pathology continues to elude current science. Despite great steps in technology, the causation and treatment is still not clear. The number of different theories and treatment modalities in the literature may confuse clinicians and patients. In this paper we outline the definitions, evolution of pathogenesis and treatment for tendinopathy. By highlighting these, the aim of this paper is to guide the practitioner in counselling and treating their patients.
Cellular, matrix, and mechano-biological differences in load-bearing versus positional tendons throughout development and aging: a narrative review
AbstractPURPOSE: Summarise available evidence comparing the cellular, biochemical, structural and biomechanical properties, and the changes that occur in these parameters in response to stimuli, in differentially loaded tendons across different stages of life. METHODS: The PubMed database was searched for literature pertaining to differences between tendons using the term "tendon" or "tendinopathy", plus one or more of the following descriptors: "loading", "positional", "weight- or load-bearing", and "energy-storing". The abstracts were reviewed and relevant full-length articles retrieved and used to assemble a narrative review. RESULTS: The incidence and prevalence of tendon disorders ("tendinopathies") is increasing in Western societies, with limited evidence that currently available treatments have any significant long-term effect on the disease course. A key emerging hypothesis is that disease in different tendons and even different regions within a tendon may be distinct. The available literature indicates that there are phenotypic differences, not only in the constitutive compositional and material properties but also in resident cells of positional compared with load-bearing tendons. Evident during early tendon growth, such differences have become well established by adulthood. CONCLUSIONS: The pheno-endotype of tendinopathy may be distinct between load-bearing tendons compared to positional tendons, which has translational implications with regard to preventing and managing tendinopathy. Better understanding of the molecular, cellular, and biomechanical pathophysiology underlying disease phenotypes, will allow more targeted/personalised treatment and therefore improve outcomes.
Efficacy of ultrasound therapy combined with cryotherapy in pain management and rehabilitation in patients with Achilles tendinopathy: a retrospective observational study.
AbstractBackground: Achilles tendinopathy (AT) is characterized by pain, reduced performance, and swelling in and around the tendon. The aim of our study was to evaluate and compare the effects of ultrasound therapy alone or associated with cryotherapy. Methods: We analyzed retrospectively amateur runner patients who run at least 3 times a week, with medical and ultrasound diagnosis of subacute AT of the midportion. All patients underwent 10 sessions of ultrasounds' therapy with qmd® ultrasound cryo and a therapeutic exercise with stretching and eccentric exercises. The Cryo-Ultrasound Group (CUG, 15, 8M and7/F), during the ultrasound treatment, underwent a session of cryo-ultrasound therapy. The Ultrasound Group (UD, 15, 7M and 8F) only performed ultrasound therapy. Results: All evaluations performed show significant improvement over time in both groups. The CUG shows at T1 a greater increase in pain and function compared to the UG. Friedmann's repeated measures analysis shows that both groups improved when assessed separately over time. From the subsequent post hoc analysis, a statistically significant difference is highlighted between the values evaluated at T0 and T3. Conclusions: The possible simultaneous delivery of the two treatment modalities, in patients suffering from tendinopathies, therefore represents a good possibility of synergistically exploiting their therapeutic actions. Future studies with a larger patient sample and longer follow-up are also needed to better evaluate the benefits of this treatment.
Journal of Manual & Manipulative Therapy · 2022 · 3 citations · open access
Manual therapy should not be on the sideline in the game of treating tendinopathy
AbstractTendinopathy is a common but difficult condition to manage in the orthopedic and sports settings. Despite strong evidence supporting exercise and load-management, a substantial proportion of individuals with the condition do not achieve a satisfactory long-term outcome. Tendinopathy can be associated with a number of impairments, including mobility deficits, muscle performance impairments, pain, and possible altered central pain processing - all of which are indications for manual therapy. Manual therapy has not been well described in the management of tendinopathy, even though its indications match the impairments associated with the condition. In this clinical perspective, the role of manual therapy in the management of tendinopathy is explored, with the intention of expanding possible treatment strategies for this challenging condition.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
